Insider Selling: David Davidson Unloads 15,000 Shares of bluebird bio Stock (BLUE)
bluebird bio (NASDAQ:BLUE) Insider David Davidson sold 15,000 shares of the company’s stock in a transaction that occurred on Friday, January 3rd. The shares were sold at an average price of $20.88, for a total value of $313,200.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
bluebird bio (NASDAQ:BLUE) traded up 2.01% during mid-day trading on Friday, hitting $21.29. 63,283 shares of the company’s stock traded hands. bluebird bio has a one year low of $17.03 and a one year high of $36.25. The stock has a 50-day moving average of $20.25 and a 200-day moving average of $25.11. The company’s market cap is $503.1 million.
bluebird bio (NASDAQ:BLUE) last released its earnings data on Tuesday, November 12th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by $0.01. The company had revenue of $6.39 million for the quarter, compared to the consensus estimate of $5.59 million. bluebird bio’s revenue was up 7417.6% compared to the same quarter last year.
bluebird bio, Inc is a clinical-stage biotechnology company, the Company is focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.